For SBTs, bilaterality was found to be significantly more common for KRAS mutant tumours (63.2% versus 26.5%, p = 0.0101, FET; Supplementary Table S6), whereas the majority of BRAFV600E mutant tumours (76.2%) were unilateral. This evidence concerns the gene KRAS and neoplasm.